Targeting integrin αvβ3 by chimeric antigen receptor neural stem cell (CAR-NSC) therapy for stroke
This study demonstrates that engineering neural stem cells with a chimeric antigen receptor targeting integrin αvβ3 enhances their retention and dispersion within peri-infarct tissue, leading to improved vascular integrity, reduced inflammation, and greater regenerative potential in a mouse model of stroke.